nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.07.2014 | Position Statement

Medical treatment in gender dysphoric adolescents endorsed by SIAMS–SIE–SIEDP–ONIG

verfasst von: A. D. Fisher, J. Ristori, E. Bandini, S. Giordano, M. Mosconi, E. A. Jannini, N. A. Greggio, A. Godano, C. Manieri, C. Meriggiola, V. Ricca, D. Dettore, M. Maggi, Italian GnRH analogs study ONIG group

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite international guidelines being available, not all gender clinics are able to face gender dysphoric (GD) youth population needs specifically. This is particularly true in Italy. Centers offering specialized support are relatively few and a commonly accepted Italian approach to GD youth has still not been defined. The aim of the present Position Statement is to develop and adhere to Italian guidelines for treatment of GD adolescents, in line with the “Dutch Approach”, the Endocrine Society (ES), and the World Professional Association for Transgender Health (WPATH) guidelines.

Methods

An in-depth brainstorming on the application of International guidelines in the Italian context was performed by several dedicated professionals.

Results

A staged approach, combining psychological support as well as medical intervention is suggested. In the first phase, individuals requesting medical help will undergo a psycho-diagnostic procedure to assess GD; for eligible adolescents, pubertal suppression should be made available (extended diagnostic phase). Finally, from the age of 16 years, cross-sex hormonal therapy can be added, and from the age of 18 years, surgical sex reassignment can eventually be performed.

Conclusions

The current inadequacy of Italian services offering specialized support for GD youth may lead to negative consequences. Omitting or delaying treatment is not a neutral option. In fact, some GD adolescents may develop psychiatric problems, suicidality, and social marginalization. With access to specialized GD services, emotional problems, as well as self-harming behavior, may decrease and general functioning may significantly improve. In particular, puberty suppression seems to be beneficial for GD adolescents by relieving their acute suffering and distress and thus improving their quality of life.

For a full account of sex and gender development see Giordano, S. (2012). Children with Gender Identity Disorder, a clinical, ethical and legal analysis. London and New York: Routledge

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, Fifth Edition: DSM-5 tm. Washington, DC

Dèttore D, Ristori J, Antonelli P, Bandini E, Fisher AD, Villani S, de Vries A, Steensma T, Cohen-Kettenis P (2014) Gender dysphoria in adolescents: the need for a shared assessment protocol and the proposal of the AGIR protocol. J Psychopathol in press

Godano A, Maggi M, Jannini EA, Meriggiola MC, Ghigo E, Todarello O, Lenzi A, Manieri C (2009) SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders. J Endocrinol Invest 32:857–864PubMedCrossRef

Fisher AD, Bandini E, Ricca V, Ferruccio N, Corona G, Meriggiola MC, Jannini EA, Manieri C, Ristori J, Forti G, Mannucci E, Maggi M (2010) Dimensional profiles of male to female gender identity disorder: an exploratory research. J Sex Med 7:2487–2498PubMed

Bandini E, Fisher AD, Ricca V, Ristori J, Meriggiola MC, Jannini EA, Manieri C, Corona G, Monami M, Fanni E, Galleni A, Forti G, Mannucci E, Maggi M (2011) Childhood maltreatment in subjects with male-to-female gender identity disorder. Int J Impot Res 23:276–285PubMedCrossRef

Caldarera A, Pfäfflin F (2011) Transsexualism and sex reassignment surgery in Italy. Int J Transgenderism 13:26–36CrossRef

Meriggiola MC, Jannini EA, Lenzi A, Maggi M, Manieri C (2010) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline: commentary from an European perspective. Eur J Endocrinol 162:831–833PubMedCrossRef

Imbimbo C, Verze P, Palmieri A, Longo N, Fusco F, Arcaniolo D, Mirone V (2009) A report from a single institute’s 14-year experience in treatment of male-to-female transsexuals. J Sex Med 6:2736–2745PubMedCrossRef

Madeddu F, Prunas A, Hartmann D (2009) Prevalence of axis II disorders in a sample of clients undertaking psychiatric evaluation for sex reassignment surgery. Psychiatr Q 80:261–267PubMedCrossRef

10.

Fisher AD, Bandini E, Casale H, Ferruccio N, Meriggiola MC, Gualerzi A, Manieri C, Jannini EA, Mannucci E, Monami M, Stomaci N, Delle Rose A, Susini T, Ricca V, Maggi M (2013) Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med 10:408–419PubMedCrossRef

11.

Bandini E, Fisher Castellini G, Lo Sauro C, Lelli L, Meriggiola MC, Casale H, Benni L, Ferruccio N, Faravelli C, Dèttore D, Maggi M, Ricca V (2013) Gender identity disorder and eating disorders: similarities and differences in terms of body uneasiness. J Sex Med 10:1012–1023PubMedCrossRef

12.

Fisher AD, Castellini G, Bandini E, Casale H, Fanni E, Benni L, Ferruccio N, Meriggiola MC, Manieri C, Gualerzi A, Jannini E, Oppo A, Ricca V, Maggi M, Rellini AH (2013) Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. J Sex Med. doi:10.1111/jsm.12413

13.

Blanchard R (1988) Nonhomosexual gender dysphoria. J Sex Res 24:188–193PubMedCrossRef

14.

Green R (1974) Sexual identity conflict in children and adults. Basic Books, New York

15.

Freund K, Langevin R, Satterberg J, Steiner B (1977) Extension of the gender identity scale for males. Arch Sex Behav 6:507–519PubMedCrossRef

16.

Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT (2005) Sex reassignment: outcomes and predictors of treatment for adolescent and adult transsexuals. Psychol Med 35:89–99PubMedCrossRef

17.

Zucker KJ, Mitchell JN, Bradley SJ, Tkachuk J, Cantor JM, Allin SM (2006) The recalled childhood gender identity/gender role questionnaire: psychometric properties. Sex Roles 54:469–483CrossRef

18.

Cohen-Kettenis PT, Pfäfflin F (2010) The DSM diagnostic criteria for gender identity disorder in adolescents and adults. Arch Sex Behav 39:499–513PubMedCrossRef

19.

Di Ceglie D, Sturge C, Sutton A (1998) Gender identity disorders in children and adolescents: Guidance for management (Council Report CR63). Royal College of Psychiatrists, London

20.

Meyer W, Boockting WO, Cohen-Kettenis P, Coleman E, Di Ceglie D, Devor H, Gooren L, Hage JJ, Kirk S, Kuiper B, Laub D, Lawrence A, Menard Y, Patton J, Schaefer L, Webb A, Wheeler CC (2002) Standards of care of the Harry Benjamin International Gender Dysphoria Association, Sixth Version. J Psychol Hum Sex 13:1–30CrossRef

21.

Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S, Adler RK, Brown GR, Devor AH, Ehrbar R, Ettner R, Eyler E, Garofalo R, Karasic DH, Lev AI, Mayer G, Meyer-Bahlburg H, Hall BP, Pfäfflin F, Rachlin K, Robinson B, Schechter LS, Tangpricha V, van Trotsenburg M, Vitale A, Winter S, Whittle S, Wylie KR, Zucker K (2011) Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism 13:165–232CrossRef

22.

Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM (2009) Endocrine treatment of transsexuals persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154PubMedCrossRef

23.

Steensma TD, Biemond R, de Boer F, Cohen-Kettenis PT (2011) Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 16:499–516PubMedCrossRef

24.

Steensma TD, McGuire JK, Kreukels BP, Beekman AJ, Cohen-Kettenis PT (2013) Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. J Am Acad Child Adolesc Psychiatry 52:582–590PubMedCrossRef

25.

de Vries AL, Steensma TD, Doreleijers TA, Cohen-Kettenis PT (2011) Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med 8:2276–2283PubMedCrossRef

26.

Giordano S (2012) Children with gender identity disorder, a clinical, ethical and legal analysis. Routledge, London and New York

27.

Delemarre-Van de Waal HA, Cohen-Kettenis PT (2006) Clinical management of gender identity disorders in adolescents: a protocol on psychological and pediatric endocrinology aspects. Eur J Endocrinol 155:S131–S137CrossRef

28.

Spack NP (2013) Management of Transgenderism. JAMA 309:478–484PubMedCrossRef

29.

Spack NP, Edwards-Leeper L, Feldman HA, Leibowitz S, Mandel F, Diamond DA, Vance SR (2012) Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics 129:418–425PubMedCrossRef

30.

Grossman AH, D’Augelli AR (2007) Transgender youth and life-threatening behaviors. Suicide Life Threat Behav 37:527–537PubMedCrossRef

31.

Skagerberg E, Parkinson R, Carmichael P (2013) Self-harming thoughts and behaviors in a group of children and adolescents with gender dysphoria. Int J Transgenderism 14:86–92CrossRef

32.

Di Ceglie D, Freedman D, McPherson S, Richardson P (2002) Children and adolescents referred to a specialist gender identity developmental service: clinical features and demographic characteristics. Int J Transgenderism 6:1

33.

Istituto Nazionale di Statistica (ISTAT) (2013). http://noi-italia.istat.it. Accessed 24 Oct 2013

34.

Achenbach TM, Rescorla LA (2001) Manual for the ASEBA school-age forms and profiles. Burlington: VT: University of Vermont, Research Centre for Children, Youth and Families

35.

Frigerio A, Cattaneo C, Cataldo MG, Schiatti A, Molteni M, Battaglia M (2004) Behavioral and emotional problems among Italian children and adolescents aged 4 to 18 years as reported by parents and teachers. Eur J Psychol Assess 20:124–133CrossRef

36.

Di Ceglie D (2012) Internalising and externalising behaviours in a group of young people with gender dysphoria. Unpublished manuscript, Gender Identity Development Service, The Tavistock and Portman NHS Foundation Trust, Tavistock Centre, London, England

37.

Zucker KJ, Bradley SJ, Owen-Anderson A, Kibblewhite SJ, Wood H, Singh D, Choi K (2012) Demographics, behavior problems, and psychosexual characteristics of adolescents with gender identity disorder or transvestic fetishism. J Sex Marital Ther 38:151–189PubMedCrossRef

38.

de Vries AL, Cohen-Kettenis PT (2012) Clinical management of gender dysphoria in children and adolescents: the Dutch approach. J Homosex 59:301–320PubMedCrossRef

39.

de Vries A, Cohen-Kettenis PT, Delemarre-Van de Waal H (2006) Clinical management of gender dysphoria in adolescents. Int J Transgenderism 9:83–94CrossRef

40.

Cohen-Kettenis PT, Delemarre-Van de Waal HA, Gooren LJG (2008) The treatment of adolescent transsexuals: changing insights. J Sex Med 5:1892–1897PubMedCrossRef

41.

Lev AI (2004) Transgender emergence-therapeutic guidelines for working with gender-variant people and their families. The Haworth Clinical Practice Press, New York-London-Oxford

42.

Ratifica ed esecuzione della convenzione sui diritti del fanciullo, L.27 maggio 1991 n.176. http://www.camera.it/_bicamerali/infanzia/leggi/l176.htm. Accessed 24 Oct 2013

43.

Heger S, Müller M, Ranke M, Schwarz H, Waldhauser F, Partsch C, Sippell WG (2006) Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol 254–255:217–220PubMedCrossRef

44.

Lazar L, Meyerovitch J, de Vries L, Phillip M, Lebenthal Y (2013) Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clin Endocrinol. doi:10.1111/cen.12319

45.

Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB Jr (1999) Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long-term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metabol 84:44–49CrossRef

46.

Heger S, Partsch CJ, Sippell WG (1999) Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metabol 84:4583–4590

47.

De Sutter P (2007) Reproduction and fertility issues for transpeople. In: Ettner R, Monstrey S, Eyler AE (eds) Principles of transgender medicine and surgery. Haworth Press, New York, pp 209–221

48.

Wierckx K, Stuyver I, Weyers S, Hamada A, Agarwal A, De Sutter P, T’Sjoen G (2012) Sperm freezing in transsexual women. Arch Sex Behav 41:1069–1071PubMedCrossRef

49.

Wylie KR, Fung R, Boshier C, Rotchell M (2009) Recommendations of endocrine treatment for patients with gender dysphoria. Sex Relat Ther 24:175–187CrossRef

50.

Kreukels BPC, Cohen-Kettenis PT (2011) Puberty suppression in gender identity disorder: the Amsterdam experience. Nat Rev Endocrinol 7:466–472PubMedCrossRef

51.

Giordano S (2007) Gender atypical organization in children and adolescents: ethic-legal issues and a proposal for new guidelines. Int J Children’s Rights 15:365–390CrossRef

52.

Edwards-Leeper L, Spack NP (2012) Psychological evaluation and medical treatment of transgender youth in an interdisciplinary “Gender Management Service” (GeMS) in a Major Pediatric Center. J Homosex 59:321–336PubMedCrossRef

53.

Delemarre-van de Waal HA (2013) Early Medical Intervention in Adolescents with Gender Dysphoria. In: Kreukels BPC, Steensma TD, de Vries ALC (eds.) Gender Dysphoria and Disorders of Sex Development. Springer New York Heidelberg Dordrecht London, pp 193–203

54.

Delemarre-van de Waal HA (2004) Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism–diagnostic and therapeutic aspects. Eur J Endocrinol 151:89–94CrossRef

55.

Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler JRGB (1988) Resumption of puberty after long term lutenizing hormone-releasing hormone treatment of central precocious puberty. J Clin Endocrinol Metabol 67:368–372CrossRef

56.

Cohen-Kettenis PT, van Goozen SHM (1997) Sex reassignment on adolescent transsexuals: a follow-up study. J Am Acad Child Adolesc Psychiatry 36:263–271PubMedCrossRef

57.

Smith YL, van Goozen SHM, Cohen-Kettenis PT (2001) Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 40:472–481PubMedCrossRef

58.

Cohen-Kettenis PT, Pfäfflin F (2003) Transgenderism and intersexuality in childhood and adolescence. Sage Publications, Making Choices. London

59.

de Vries AL (2010) Gender dysphoria in adolescents: mental health and treatment evaluation. Doctoral dissertation, VU University, Amsterdam

60.

Cohen-Kettenis PT, Schagen SE, Steensma TD, de Vries AL, Delemarre-van de Waal HA (2011) Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up. Arch Sex Behav 40:843–847PubMedCentralPubMedCrossRef

61.

Bertelloni S, Dati E, Baroncelli GI (2008) Disorders of sex development: hormonal management in adolescence. Gynecol Endocrinol 24:339–346PubMedCrossRef

62.

Palmert MR, Dunkel L (2012) Delayed puberty. N Engl J Med 366:443–453PubMedCrossRef

63.

Buvat J, Maggi M, Guay A, Torres LO (2013) Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 10:245–284PubMedCrossRef

64.

Han TS, Bouloux PM (2010) What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf) 72:731–737CrossRef

65.

Poomthavorn P, Suphasit R, Mahachoklertwattana P (2011) Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol 27:524–528PubMedCrossRef

66.

Drobac S, Rubin K, Rogol AD, Rosenfield RL (2006) A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab 19:55–64PubMedCrossRef

67.

Davenport ML (2010) Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 95:1487–1495PubMedCrossRef

68.

Bondy CA, Turner Syndrome Study Group (2007) Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10–25PubMedCrossRef

69.

Kelly JJ, Rajkovic IA, O’Sullivan AJ, Sernia C, Ho KK (1993) Effects of different oral estrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 39:561–567CrossRef

70.

Yigit S, Onyirimba M, Gendreau P, Lerer T, Rubin K (2004) Effect of transdermal versus oral estradiol on growth factors and markers of bone turn-over in young adults with Turner Syndrome: a pilot study. J Bone Miner Res 19:S320

71.

O’Sullivan AJ, Crampton LJ, Freund J, Ho KK (1998) The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 102:1035–1040PubMedCentralPubMedCrossRef

72.

Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H (2001) Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 85:619–625PubMed

73.

Möller B, Schreier H, Li A, Romer G (2009) Gender identity disorder in children and adolescents. Curr Probl Pediatr Adolesc Health Care 39:117–143PubMedCrossRef

74.

Spack N (2008) An endocrine perspective on the care of transgender adolescents. Presented at the 55th annual meeting of the American Academy of Child and Adolescent Psychiatry, 28 October–2 November 2008

75.

Cohen-Kettenis PT, Steensma TD, de Vries AL (2011) Treatment of adolescents with gender dysphoria in the Netherlands. Child Adolescent Psychiatr Clin N Am 20:689–700CrossRef

Titel: Medical treatment in gender dysphoric adolescents endorsed by SIAMS–SIE–SIEDP–ONIG
verfasst von: A. D. Fisher
J. Ristori
E. Bandini
S. Giordano
M. Mosconi
E. A. Jannini
N. A. Greggio
A. Godano
C. Manieri
C. Meriggiola
V. Ricca
D. Dettore
M. Maggi
Italian GnRH analogs study ONIG group
Publikationsdatum: 01.07.2014
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 7/2014
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0077-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2014

Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic β cells

Transition from pediatric to adult care. Eight years after the transition from pediatric to adult diabetes care: metabolic control, complications and associated diseases

High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment

Orazio Marinali (1643–1720)

Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes